公司资料
Sientra 股价、新闻与催化剂
- 股票代码:
- SIEN
- 交易所:
- NASDAQ
- 行业:
- MedTech
- 所在地:
- United States
股价为何变动
Current closing-price context is not available for SIEN.
公司概览
业务概览
Sientra was a medical aesthetics company focused on breast implants and related surgical products before being acquired. Its story was rooted in device and procedure demand rather than drug development.
所在地与行业分类
Sientra was headquartered in the United States and traded on NASDAQ before the acquisition. It sat in medical devices and aesthetics.
商业模式特征
The business depended on product sales, surgeon adoption, and procedure volume in aesthetic surgery. Investors historically watched commercialization, litigation or regulatory issues, and margin trends.
生物医药行业定位
Sientra was a medtech and aesthetics name, not a biotech developer. Because it has been acquired, it now belongs to the historical healthcare M&A set.
未来催化剂
- Sientra’s catalysts are breast-implant and reconstructive-surgery demand, along with operating execution. The company moves on procedural demand and commercial stability.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。